Skip to content


Fellows Directory

Mervyn Bibb

Mervyn Bibb

Professor Mervyn Bibb FRS


Elected: 2013


Mervyn Bibb is a molecular microbiologist who has made a major contribution to our understanding of antibiotic production and its regulation by bacteria. The growing increase in antibiotic resistance seen in clinical pathogens has resulted in an urgent need for new anti-infective agents.

His research concentrates on Actinobacteria, the main source of clinically useful antibiotics. He invented technology for introducing DNA into these organisms, enabling researchers to not only understand in detail how antibiotics are made, but also to genetically manipulate the producing organisms to generate new compounds. More recently, he has applied genome sequencing and genomic approaches to identify gene clusters for several potentially clinically useful antibiotics.

Mervyn has published more than 190 research papers and presented his work at over 70 international conferences. He is the recipient of the Lepetit Award, the Colworth Prize, the Charles Thom Award, the Heatley Medal and the David Gottlieb Medal for his work on antibiotic biosynthesis. Research from his group led to the formation of two companies, Novacta Biosystems and Procarta Biosystems, each focused on developing new anti-infective treatments.

Interest and expertise

Subject groups

  • Biochemistry and molecular cell biology
    • Molecular microbiology, Biochemistry and molecular biology


Antibiotics, Actinobacteria, Antibiotic resistance, Genome analysis, Gene regulation

Was this page useful?
Thank you for your feedback
Thank you for your feedback. Please help us improve this page by taking our short survey.